Sedana Medical AB (publ), Interim report Q1, 2018. Record-breaking sales and increased market presence
Financial Summary January-March · Net sales during the third quarter amounted to 15 487 (9 892) KSEK corresponding to an increase of 57% compared with the same period in 2017. · Earnings before interest, taxes, depreciation and amortization (EBITDA) amounted to -788 (408) KSEK. This corresponds to an EBITDA margin of -5,1% (4,1%). · Earnings before interest and taxes (EBIT) amounted to -1 730 (270) KSEK, which corresponds to an EBIT margin of -11,2% (2,7%). · Cash flow from operations before changes in working capital amounted to -821 (279) KSEK. · Liquid